CD10 as a Marker for Childhood Acute Lymphoblastic Leukaemia
Author Information
Author(s): Cutrona G, Tasso P, Dono M, Roncella S, Ulivi M, Carpaneto E M, Fontana V, Comis M, Morabito F, Spinelli M, Frascella E, Boffa L C, Basso G, Pistoia V, Ferrarini M
Primary Institution: Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Hypothesis
Does CD10 expression correlate with cycling and apoptotic abilities in childhood acute lymphoblastic leukaemia cells?
Conclusion
CD10-positive acute lymphoblastic leukaemia cells are actively cycling and prone to apoptosis, while CD10-negative cells are not.
Supporting Evidence
- CD10-positive cells showed higher levels of c-myc and greater cycling capacities.
- CD10-negative cells had lower c-myc levels and were resistant to apoptosis.
- Significant differences in apoptosis rates were observed between CD10-positive and CD10-negative groups.
Takeaway
This study found that children with a type of blood cancer called acute lymphoblastic leukaemia have cells that can be marked by a protein called CD10, which helps show how fast the cells are growing and how likely they are to die.
Methodology
The study analyzed bone marrow aspirates from 28 children with acute lymphoblastic leukaemia, comparing CD10-positive and CD10-negative cells for cycling and apoptotic abilities.
Potential Biases
Potential bias in sample selection as all patients were untreated at the onset of disease.
Limitations
The study did not explore the long-term clinical outcomes associated with CD10 expression.
Participant Demographics
Children with a mean age of 6.8 years diagnosed with acute lymphoblastic leukaemia.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website